Doxorubicin Hydrochloride 12064-0019-01
- Manufacturer
- Glaxosmithkline Manufacturing Spa
- Dosage Form
- Injection, Suspension, Liposomal
- Product Type
- Drug For Further Processing
- Marketing Start
- January 1, 2015
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Doxorubicin Hydrochloride | 2 mg/mL |
Selected Package
12064-0019-01Selected50 VIAL in 1 CASE (12064-019-01) / 25 mL in 1 VIAL
Other packages for this product(1)
98 VIAL in 1 CASE (12064-019-00) / 10 mL in 1 VIAL